Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cabazitaxel”

115 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 115 results

Testing effectiveness (Phase 2)WithdrawnNCT02035124
What this trial is testing

Cabazitaxel and BKM120 in Patients With Metastatic Castrate-Resistant Prostate Cancer (mCRPC) Previously Treated With Docetaxel

Who this might be right for
Advanced Prostate Cancer
SCRI Development Innovations, LLC
Testing effectiveness (Phase 2)UnknownNCT03257891
What this trial is testing

Cabazitaxel Activity in Patients With Advanced AdrenoCortical-Carcinoma Progressing After Previous Chemotherapy Lines

Who this might be right for
Adrenocortical Carcinoma
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia 25
Early research (Phase 1)Study completedNCT00925743
What this trial is testing

Evaluate the Effects of Combining Cabazitaxel With Cisplatin Given Every 3 Weeks in Patients With Advanced Solid Cancer

Who this might be right for
Solid Cancer
Sanofi 76
Testing effectiveness (Phase 2)Study completedNCT01693549
What this trial is testing

Study of Cabazitaxel in Patients With Metastatic Breast Cancer Previously Treated With Taxanes

Who this might be right for
Breast Cancer
Hellenic Cooperative Oncology Group 84
Large-scale testing (Phase 3)Study completedNCT01578655
What this trial is testing

Comparison of Cabazitaxel/Prednisone Alone or in Combination With Custirsen for 2nd Line Chemotherapy in Prostate Cancer

Who this might be right for
Prostate Cancer
Achieve Life Sciences 630
Testing effectiveness (Phase 2)Ended earlyNCT02166658
What this trial is testing

Cabazitaxel for Patients With Breast or Lung Cancer and Recurrent or Progressive Brain Metastases - Cabazitaxel for Brain Metastases (CaBaMet)

Who this might be right for
Breast CancerLung CancerRecurrent Brain Metastases+1 more
AIO-Studien-gGmbH 8
Testing effectiveness (Phase 2)WithdrawnNCT01913067
What this trial is testing

Evaluation of Cabazitaxel in Patients With Brain Metastasis Secondary to Breast Cancer and NSCLC

Who this might be right for
Brain MetastasisBreast CancerNon Small Cell Lung Cancer
Jules Bordet Institute
Testing effectiveness (Phase 2)Ended earlyNCT01747239
What this trial is testing

Cabazitaxel in Platinum Refractory Ovarian Cancer

Who this might be right for
Ovarian Cancer
Vejle Hospital 4
Testing effectiveness (Phase 2)Study completedNCT04495179
What this trial is testing

AZD4635 With Durvalumab and With Cabazitaxel and Durvalumab in Patients With mCRPC.

Who this might be right for
Progressive Metastatic Castrate-Resistant Prostate Cancer
AstraZeneca 30
Testing effectiveness (Phase 2)Study completedNCT03114254
What this trial is testing

A Trial of Cabazitaxel Chemotherapy in Relapsed Locally Advanced &/or Metastatic Carcinoma of the Penis

Who this might be right for
Penile Neoplasm
University Hospitals Bristol and Weston NHS Foundation Trust 17
Large-scale testing (Phase 3)UnknownNCT01830231
What this trial is testing

Cabazitaxel vs. Vinflunine in Metastatic or Locally Advanced Transitional Cell Carcinoma of the Urothelium (TCCU)

Who this might be right for
Urothelium Transitional Cell Carcinoma
Associació per a la Recerca Oncologica, Spain 372
Post-approval studies (Phase 4)Ended earlyNCT02441517
What this trial is testing

Enzalutamide Re-treatment in Metastatic Castration-resistant Prostate Cancer After Docetaxel and/or Cabazitaxel Treatment

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
Astellas Pharma Global Development, Inc. 4
Early research (Phase 1)WithdrawnNCT03110588
What this trial is testing

Phase I Trial of PACE for Metastatic Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
University of Alabama at Birmingham
Large-scale testing (Phase 3)Ended earlyNCT01083615
What this trial is testing

A Study Evaluating the Pain Palliation Benefit of Adding Custirsen to Docetaxel Retreatment or Cabazitaxel as Second Line Therapy in Men With Metastatic Castrate Resistant Prostate Cancer (mCRPC)

Who this might be right for
Castrate-Resistant Prostate CancerHormone Refractory Prostate Cancer
Achieve Life Sciences 14
Testing effectiveness (Phase 2)Active Not RecruitingNCT02522715
What this trial is testing

Enzalutamide and Cabazitaxel in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Prostate CarcinomaRecurrent Prostate Carcinoma+1 more
OHSU Knight Cancer Institute 37
Testing effectiveness (Phase 2)Active Not RecruitingNCT04592237
What this trial is testing

Cabazitaxel, Carboplatin, and Cetrelimab Followed by Niraparib With or Without Cetrelimab for the Treatment of Aggressive Variant Metastatic Prostate Cancer

Who this might be right for
Aggressive Variant Prostate CarcinomaCastration-Resistant Prostate CarcinomaMetastatic Prostate Carcinoma+3 more
M.D. Anderson Cancer Center 120
Testing effectiveness (Phase 2)Study completedNCT02543255
What this trial is testing

Anti-Androgens and Cabazitaxel in Defining Complete Response in Prostatectomy (ACDC Trial)

Who this might be right for
Prostate Cancer
University Health Network, Toronto 76
Testing effectiveness (Phase 2)UnknownNCT03050866
What this trial is testing

Cabazitaxel in mCRPC Patients With AR-V7 Positive Circulating Tumor Cells (CTCs)

Who this might be right for
Circulating Tumor CellMetastatic Prostate Cancer
Erasmus Medical Center 140
Early research (Phase 1)WithdrawnNCT01981668
What this trial is testing

The JET Study: a Phase I Trial of Cabazitaxel, Radiotherapy and Long-term Androgen Deprivation

Who this might be right for
Prostatic Neoplasms
Nova Scotia Cancer Centre
Testing effectiveness (Phase 2)Study completedNCT02985957
What this trial is testing

Nivolumab Plus Ipilimumab, Ipilimumab Alone, or Cabazitaxel in Men With Metastatic Castration-Resistant Prostate Cancer (CheckMate 650)

Who this might be right for
Prostate Cancer
Bristol-Myers Squibb 351
Load More Results